Pelvic conditions include diseases of the uterus, such as uterine fibroids and menorrhagia. Uterine fibroids are non-cancerous tumors of the uterus that typically appear on the endometrium layer (i.e., uterine wall) of the uterus. Menorrhagia is a medical condition involving excessive and difficult to control bleeding of the endometrial layer of the uterus. These conditions have been treated through hysterectomy. However, alternative, less radical approaches are also being used.
One alternative to a hysterectomy is endometrial ablation, which induces necrosis of the endometrial layer and a portion of the myometrial layer. These treatments can include freezing and heating the endometrial layer, or cauterizing the endometrial layer using a laser.
Some embodiments of the invention are directed to a laser ablation system. In one embodiment, the laser ablation system comprises a shaft, a balloon, a laser fiber and a viewing fiber. The shaft has a proximal end and a distal end. The balloon is attached to the distal end of the shaft, a portion of which is within the balloon. The laser fiber has a distal end comprising a light dispenser that is configured to deliver laser light through the balloon. The viewing fiber is configured to image an interior balloon.
In accordance with another embodiment, the laser ablation system comprises a shaft, a balloon and a laser fiber. The shaft has a proximal end and a distal end. The balloon is attached to the distal end of the shaft, which is within the balloon. The balloon includes an inflated state, in which the balloon is shaped to conform to a cavity of a patient. The laser fiber has a distal end comprising light dispenser that is configured to deliver laser light through the balloon.
Additional embodiments are directed to a method a using the laser ablation system. In one embodiment, a laser ablation system is provided that comprises a shaft, a balloon and a laser fiber. The shaft has a proximal end and a distal end. The balloon is attached to the distal end of the shaft, which is within the balloon. The balloon includes an inflated state, in which the balloon is shaped to conform to a uterine cavity of a patient. The laser fiber has a distal end comprising a light dispenser that is configured to deliver laser light through the balloon. Also in the method, the distal end of the shaft is fed into the uterus of a patient with the balloon in a deflated state. The balloon is inflated with a gas or fluid to the inflated state, in which the balloon substantially conforms to the uterine cavity of the patient and engages the uterine walls. Laser light is then transmitted through the laser fiber and, the light dispenser and the balloon. The tissue of the uterine walls is ablated responsive to the transmission of the laser light.
Embodiments of the present invention are directed to a laser tissue ablation system designed to perform tissue ablation and/or other laser treatments on a patient. While particular embodiments of the invention will be described as useful in treating menorrhagia through endometrial ablation of the uterine wall of a patient, those skilled in the art understand that the system of a present invention may be adapted to perform ablation treatments of other tissue of a patient, such as that of the anal cavity, the bladder, the vagina, the esophagus, the trachea, the urethra, the ureter, the prostate gland, the kidney, intestinal growths or abnormal tissues of the intestine (e.g., hemorrhoids, polyps, etc.) and cancerous tissues.
One embodiment of the applicator 102 comprises a shaft 104 having a proximal end 106 and a distal end 108. One embodiment of the shaft 104 is formed of a rigid and substantially transparent material, such as, for example, acrylic, PET, silicone, polyurethane, polycarbonate, glass or other suitable material. In one embodiment, the applicator 102 includes a balloon 110 that is attached to the shaft 104 proximate the distal end 108. In one embodiment, the balloon 110 comprises a proximal end 112 and a distal end 114. In one embodiment, the proximal end 112 is attached to the shaft 104 by a sleeve 116 that is formed, for example out of Teflon®, which seals an opening of the balloon 110 to the shaft 104.
In one embodiment, the distal end 108 of the shaft 104 is attached to the distal end 114 of the balloon 110. In one embodiment, the shaft 104 has a longitudinal axis 117. In one embodiment, the distal end 108 of the shaft 104 is secured to the distal end 114 of the balloon 110 along longitudinal axis 117. In one embodiment, the longitudinal axis 117 is aligned with a central axis 118 of the balloon 110. In one embodiment, the balloon is symmetric about the longitudinal or central axis 117 when inflated.
The attachment of the balloon 110 to the shaft 104 can be accomplished in many different ways.
The balloon 110 has deflated and inflated states. The deflated state 124 of the balloon 110 is preferably sufficiently compact to allow the distal end 108 of the shaft 104 and the attached balloon 110 to be inserted into the desired cavity of the patient, such as the uterus or vagina, to locate the balloon 110 proximate the tissue targeted for treatment. In one embodiment, the deflated state of the balloon 110 is approximately 4-6 mm or less in diameter measured radially from the central axis 118 of the balloon 110. When in the inflated state, the balloon 110 substantially conforms to the cavity in which it is placed.
In one embodiment, the balloon 110 is be formed of a suitable biocompatible material. In one embodiment, the balloon 110 is formed of a distensible material, such as silicone, PET, polyurethane, rubber or other suitable material. The distensible material can stretch responsive to inflating the balloon 110 from a deflated state 124 (illustrated in phantom in
In accordance with another embodiment, the balloon 110 is formed of minimally distensible material, such as polyurethane, or other suitable material.
In one embodiment, the balloon 110 includes an Inhibizone coating, such as that described in U.S. Pat. No. 5,756,145, which is incorporated herein by reference in its entirety.
In accordance with another embodiment, the inflated state 126 of the balloon 110 has a predefined non-cylindrical or spherical shape when viewed in a plane aligned with the central axis of the balloon 117. Rather, the inflated state 126 of the balloon has a shape that conforms to the interior cavity of the patient where the tissue targeted for ablation is located. One exemplary embodiment is illustrated in the simplified side view of
When the balloon 110 is formed of substantially non-distensible material, the predefined inflated shape 126 of the balloon 110 will drive the tissue of the cavity into conformity with the balloon 110. When the balloon 110 is formed distensible material, the inflated state 126 of the balloon will generally conform to the cavity of the patient. As a result, the balloon 110 may only minimally deflect the walls of the cavity when the balloon is inflated. Further, the balloon 110 will also deform in response to engagement with the walls of the cavity.
In one embodiment, the pre-defined shape of the inflated state 126 of the balloon prevents the balloon from applying significant pressures to the walls of the cavity of the patient. In one embodiment, the balloon 110 applies less than 10 psi to the walls of the cavity of the patient in which it is inflated. Thus, the balloon 110 having a pre-defined inflated shape can significantly reduce the pressure on the walls of the cavity of the patient in which the balloon 110 is inflated. This can reduce patient intraoperative and post operative pain.
In one embodiment, the balloon 110 includes markings 139, as shown in
In one embodiment, the balloon 110 seals the distal end 108 of the shaft 104. A seal 142, such as an o-ring, or other suitable seal, seals the proximal end 106 of the shaft 104. In one embodiment, the balloon 110 is inflated using a simple saline solution.
In one embodiment, the balloon 110 may be inflated with fluid or gas. In one embodiment, the shaft 104 includes a port 140, as shown in
In one embodiment, gas or fluid enters the shaft 104 through the port 140, shown in
In accordance with one embodiment, the balloon 110 comprises an interior balloon 110A and an exterior balloon 110B, as shown in the simplified side-cross sectional view of FIG. 8. In accordance with one embodiment, either the interior balloon 110A or the exterior balloon 110B is formed of a non-distensible material, while the other balloon 110A or 110B is formed of a distensible material. In one embodiment, the interior balloon 110A is formed of a substantially non-distensible or minimally distensible material and has a predefined shaped in accordance with embodiments described above. In accordance with one embodiment, a biocompatible lubricant is located between the interior balloon 110A and the exterior balloon 110B.
In accordance with one embodiment, the fluid or gas driven through the port 140 is fed between the interior balloon 110A and the exterior balloon 110B, as represented by the arrows in
One embodiment of the system 100 includes a conventional laser source 160 that can be attached to a waveguide 162, such as an optical fiber (hereinafter “laser fiber”), that can be received within the shaft 104. The laser source 160 can be a conventional laser generating system. In accordance with one embodiment, the laser source 160 is configured to generate laser light or a laser 164 having a desired wavelength for performing surgical procedures, such as tissue ablation.
In one embodiment, the laser source 160 is configured to produce an Nd:YAG laser operating at approximately 532 nanometers or 1064 nanometer wavelengths. The laser source 160 may be a solid state laser based on a potassium-titanyl-phosphate (KTP) crystal, a lithium triborate (LBO) laser, a beta barium borate (BBO), a holmium laser and a thulium laser, or other type of laser source used to perform tissue ablation or other laser treatment. Exemplary laser sources 160 are described in U.S. Pat. No. 6,986,764 (Davenport), which is incorporated herein by reference in its entirety.
The laser 164 generated by the laser source 160 travels through the laser fiber 162 and is discharged through a light dispenser 166 at a distal end 168. In one embodiment, the dispensed laser light 164 is transmitted through the shaft 104 and the balloon 110 and onto the targeted tissue of the patient, such as the uterine wall 138 shown in
The light dispenser 166 is configured to discharge the laser light 164 in a desired manner, such as along the axial and/or radial directions of the laser fiber 162, to one side of the laser fiber 162, in a diffuse pattern around the dispenser 166, and/or other desired manner. Exemplary light dispensers 166, such as side-fire optical caps, are disclosed in U.S. Pat. No. 5,428,699 (Pon), U.S. Pat. No. 5,269,777 (Doiron et al.), U.S. Pat. No. 5,530,780 (Ohsawa), and U.S. Pat. No. 5,807,390 (Fuller et al.).
In one embodiment, the light dispenser 166 comprises an etched section 170 of the laser fiber 162, as shown in
If the laser light 164 is output from the dispenser 166 in an even dispersion pattern, the targeted tissue located farther away will receive less laser light energy than the targeted tissue located closer to the dispenser 166. In one embodiment, the etching pattern of the section 170 is customized to include portions that transmit more light energy than other portions to customize the laser energy dispersion pattern output from the dispenser 166. That is, the etched section 170 may comprise different patterns in different portions of the section 170 to provide different levels of laser light transmission through the different portions of the section 170. This allows the targeted tissue to receive similar intensity levels of the dispensed laser light 164 even though the targeted tissue is not located a uniform distance from the dispenser 166.
In accordance with one embodiment, light transmission through the balloon 110 is non-uniform. In one embodiment, light transmission through the balloon varies along the central axis 118 of the balloon 110. That is, portions of the balloon 110 at different locations along the axis 118 (e.g., portions in a plane that is perpendicular to the axis 118) have a degree of laser transparency that is different from other portions of the balloon along the axis 118. This allows for the control of the transmission of the laser light 164 through the balloon 110 and, therefore, the amount of laser energy that is delivered to the targeted tissue.
In one embodiment, the material forming the balloon provides a predefined pattern of laser transparency variation along the axis 118, such as, for example, by varying a thickness of the balloon 110. In one embodiment, printing or a coating of material on of the balloon 110, such as on the interior wall 190 (
In one embodiment, the distal end 108 of the shaft 104 is configured to transmit the laser light 164 discharged through the dispenser 166 of the laser fiber 162 at varying degrees of efficiency. That is, sections of the shaft 104 are configured to be more transparent to the laser light 164 than other sections of the shaft 104. This pattern of laser transparency of the shaft may be formed in various ways. In one embodiment, the interior or exterior wall of the shaft 104 is coated as described above with regard to the balloon 110. Alternatively, the pattern may be formed on the shaft 104 by etching the pattern on the shaft 104, applying a particulate to the shaft 104 that blocks the laser light 164, tinting the shaft 104, or other suitable technique for creating the desired pattern of laser transparency through the shaft 104. As discussed above with regard to the dispenser 166 illustrated in
One embodiment of the system 100 includes one or more laser fiber positioning components 180 represented schematically in
In accordance with another embodiment, the laser fiber positioning components 180 are configured to rotate the laser fiber 162 about its longitudinal axis and, thus, rotate (i.e., move angularly) the dispenser 166 about the longitudinal axis. This may be useful when the dispenser 166 is configured to output the laser light 164 radially out a side of the dispenser 166 over a range of less than 360°. With such a configuration, the dispenser 166 can be made to output the laser light 164 to the tissue surrounding the dispenser 166 by rotating the dispenser 360° using the positioning components 180.
In accordance with one embodiment, the one or more positioning components 180 are configured to move the distal end 168 of the laser fiber 162 in an arc relative to the balloon 110.
One embodiment of the system 100 includes a viewing system 200 that is configured to provide the physician with a view from the interior 128 of the balloon 110. One embodiment of the viewing system 200 comprises a viewing fiber 202 that is received within the shaft 104, as shown in
In one embodiment, the viewing system 200 includes one or more viewing fiber positioning components 210 that are configured to adjust the position and/or orientation of the imaging component 206 to image the desired portion of the balloon 110 or the targeted tissue of the patient. In one embodiment, the positioning components 210 are configured to move the viewing fiber 202 axially along the longitudinal axis of the viewing fiber, as indicated by arrow 211 in
Exemplary positioning components for the laser fiber 162 and the components 210 for the viewing fiber 202 include components that facilitate the hand feeding of the fibers 162 and 202, and components that drive the feeding of the laser fiber 162 and the viewing fiber 202, such as rollers that are rotated by hand or driven by a motor, or other suitable mechanism for feeding the laser fiber 162 and the viewing fiber 202 in their axial directions. In one embodiment, the components 180 and 210 are configured to rotate the laser fiber 162 and the viewing fiber 202, respectively, and include components that facilitate the rotation of the fibers by hand, mechanisms that are driven by hand or by a motor that engage the fibers and rotate the fibers about their longitudinal axis, or other components that can be used to rotate the fibers.
Another embodiment of the system 100 includes one or more sensors 212 (
One embodiment of the applicator 102 comprises a handheld unit 220, an exemplary embodiment of which is illustrated in
In one embodiment, the handheld unit 220 allows the laser fiber 162 to pass through the body of the unit 220 for attachment to the laser system 160. Similarly, the handheld unit 220 allows for the viewing fiber 202 to pass through the body of the unit 220 for coupling to the viewing system 208.
In one embodiment, the handheld unit 220 supports a laser actuator 222 that is configured to trigger the laser system 160 to deliver laser energy down the laser fiber 162 to the distal end 168. Embodiments of the laser actuator 222 include a button, a finger trigger, or other suitable mechanism. One embodiment of the laser actuator 222 that is not supported by the handheld unit 220 is a foot-activated switch.
In one embodiment, the support 232 and/or the cover 234 comprise a channel 244 that is configured to receive the laser fiber 162, as best shown in
Another embodiment of the handheld unit 220 comprises a channel 246 formed in the support 232 and/or the cover 234, as best shown in
In one embodiment, the handheld unit 220 includes a channel 248 configured to receive conduit 250 that is coupled to the fluid input port 140, as shown in
As discussed above, one embodiment of the handheld unit 220 includes the one or more laser fiber positioning components 180. In one embodiment, the laser fiber positioning components 180 comprise a thumb wheel 252 that is coupled to a roller 252 through a gear, axle, or other suitable arrangement, as shown in
One embodiment of the one or more viewing fiber positioning components 210 includes a thumb wheel 258 and a roller 260 that operate similarly to the thumb wheel 252 and roller 254 described above to move the viewing fiber 202 in the longitudinal direction relative to the handheld unit 220, the shaft 104 and the balloon 110. The thumb wheel 258 is coupled to the roller 260 through a suitable arrangement, such as a gear. The roller 260 is exposed to engage the viewing fiber 202 through a slot 262 in the support 232. The roller 260 comprises an exterior surface that is formed of a material (e.g., rubber) that generates sufficient frictional resistance with the viewing fiber 202 to inhibit sliding contact between the roller 260 and the viewing fiber 202 as the roller 260 is rotated. Rotation of the thumb wheel 258 causes the roller 260 to rotate, which drives the viewing fiber in the longitudinal direction relative to the handheld unit 220, the shaft 104 and the balloon 110. Thus, the longitudinal position of the distal end 204 of the viewing fiber 202 can be positioned as desired relative to the balloon 110 using the thumb wheel 258.
Another embodiment of the handheld unit 220 comprises one or more viewing fiber positioning components 210 that are configured to rotate the viewing fiber 202 about its longitudinal axis. One embodiment of the components 210 comprise a rotatable member 264, such as a thumb wheel, and a roller 266. The rotatable member 264 is coupled to the roller 266 through an axle, gear, or other suitable arrangement, such that rotation of the member 264 causes the roller 266 to rotate. In one embodiment, the axes of rotation of the member 264 and the roller 266 are parallel to the longitudinal axis of the viewing fiber 202 and the channel 246. The roller 266 engages the viewing fiber 202 through a slot 268. The exterior surface of the roller 266 is formed of a material (e.g., rubber) that produces sufficient frictional resistance with the viewing fiber 202 to inhibit sliding contact with the viewing fiber 202 as the roller 266 rotates. The rotation of the member 264 causes the roller 266 to rotate, which drives the rotation of the viewing fiber 202 about its longitudinal axis. This allows the distal end 204 of the viewing fiber 202 to be rotated as desired within the balloon 110. One embodiment of the one or more laser fiber positioning components 180 includes components that are similar to the rotatable member 264 and the roller 266 that can be used to rotate the laser fiber 162 about its longitudinal axis.
In one embodiment, the handheld unit 220 includes the laser actuator 222 in the form of a trigger 270 that is mounted to the support 232. In one embodiment, actuation of the trigger 270 directs the laser system 160 to transmit laser light through the laser fiber 162 for discharge through the dispenser 166.
In one embodiment, the shaft 104, the balloon 110, the laser fiber 162, the viewing fiber 202, the tubing 250, and/or the port 140 form a disposable group of components. In one embodiment, one or more of these components are provided as a kit in sterilized packaging. In one embodiment, one or more of these components come pre-assembled. For instance, a disposable assembly may comprise the shaft 104, the balloon 110, the laser fiber 162 and the tubing, as shown in
Additional embodiments of the invention include methods of ablating tissue of a patient, or performing another laser treatment, using the system 100. In one embodiment of the method, the system 100 formed in accordance with one or more embodiments described above is provided and the system is prepared for the ablation operation. This may involve the providing of the disposable assembly described above in, for example, sterilized packaging. The disposable assembly is then installed in the handheld unit 202.
In one embodiment, the laser fiber 162 is connected to the laser system 160. In one embodiment, the viewing fiber 202 (if present) is connected to the viewing console 208. In one embodiment, the tubing 250 is fluidically coupled to the pump 144. In one embodiment, connections are made between the one or more sensors 212 and the controller 214.
In one embodiment, a coating, such as an adjuvant, is applied to the exterior surface of the balloon 110, which is placed in contact with the target tissue when the balloon 110 is inflated within the cavity of the patient. The adjuvant is designed to enhance laser tissue ablation by absorbing the wavelength of laser light that will be applied to the tissue. Embodiments of the coating are described in U.S. patent application Ser. No. 12/468,668 filed May 19, 2009 entitled “ADJUVANT ENHANCED ABLATION,” which is incorporated herein by reference in its entirety.
In one embodiment, the balloon 110 is placed in the deflated state 124 and the distal end 108 of the shaft 104 is fed into the cavity of the patent, such as the uterus, where the target tissue is located. In one embodiment, the cavity is visually inspected using the viewing fiber 202.
In one embodiment, the balloon 110 is inflated within the cavity by pumping either fluid or gas through the tubing 250 and the port 140, such as using the pump 144. In one embodiment, the inflated state 126 of the balloon engages the interior wall of the cavity, such as illustrated in
In one embodiment, the cavity and the inflated balloon 110 are inspected using the viewing fiber 202. This involves moving the distal end 204 of the viewing fiber 202 axially and/or angularly using the one or more viewing fiber positioning components 210.
In one embodiment, the markings 139 on the balloon are imaged or viewed using the viewing fiber 202. The markings indicate whether the balloon 110 is properly inflated and/or positioned within the cavity of the patient. In one embodiment, the balloon 110 is deflated, repositioned and inflated again until the markings 139 indicate that the balloon 110 is fully inflated and/or in the desired position within the cavity.
In one embodiment, the laser fiber 162 is positioned as desired relative to the shaft 104 and the balloon 110 using the one or more laser fiber positioning components 180. This may involve moving the distal end 168 axially, angularly, or along an arc.
In one embodiment, the laser system 160 is activated to transmit laser light 164 through the laser fiber 162 and out the dispenser 166 to ablate the targeted tissue. In one embodiment, this activation of the laser system is responsive to the actuation of the laser actuator 222. In one embodiment, the targeted tissues are inspected using the viewing fiber 202.
In one embodiment, the dispenser 166, the distal end 108 of the shaft 104, and/or the balloon 110 are configured to provide substantially uniform transmission of the laser light 164.
In one embodiment, the dispenser 166, the distal end 108 of the shaft 104, and/or the balloon 110 are configured to provide non-uniform transmission of the laser light to control the exposure of the target tissue to the laser light. In one embodiment, a coating is applied to the shaft 104 and/or the interior of the balloon 110 to control the transmission of the laser light therethrough.
In one embodiment, the distal end 168 of the laser fiber 162 is moved along an arc and/or axially to another position relative to the shaft 104 and the balloon 110 to target other tissue within the cavity of the patient.
In one embodiment, a flow of fluid or gas is circulated through the balloon 110. In one embodiment, the flow of fluid or gas is regulated responsive to a temperature signal from a temperature sensor 212.
Following the completion of the ablation treatment, the balloon 110 is returned to its deflated state 124 and the balloon 110, the shaft 104, the laser fiber 162 and other components of the system (e.g., the viewing fiber 202) are removed from the cavity. The disposable components can then be detached from the laser system 160, the pump 144 and the viewing console 208, removed from the applicator 102 and discarded.
Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.
This application is a continuation of U.S. application Ser. No. 14/521,831, filed Oct. 23, 2014, now U.S. Pat. No. 9,433,467, which is a continuation of U.S. application Ser. No. 13/152,825, filed Jun. 3, 2011, now U.S. Pat. No. 8,936,592, which claims the benefit of U.S. Provisional Application No. 61/351,127, filed Jun. 3, 2010. The contents of all off the above-referenced applications are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4976710 | Mackin | Dec 1990 | A |
4998930 | Lundahl | Mar 1991 | A |
5061265 | Abela et al. | Oct 1991 | A |
5074632 | Potter | Dec 1991 | A |
5102402 | Dror et al. | Apr 1992 | A |
5125925 | Lundahl | Jun 1992 | A |
5269777 | Doiron et al. | Dec 1993 | A |
5344419 | Spears | Sep 1994 | A |
5409483 | Campbell | Apr 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5428699 | Pon | Jun 1995 | A |
5431647 | Purcell, Jr. et al. | Jul 1995 | A |
5437660 | Johnson | Aug 1995 | A |
5458595 | Tadir et al. | Oct 1995 | A |
5530780 | Ohsawa | Jun 1996 | A |
5533508 | Doiron | Jul 1996 | A |
5569240 | Dowiatshahi et al. | Oct 1996 | A |
5593405 | Osypka | Jan 1997 | A |
5609591 | Daikuzono | Mar 1997 | A |
5645562 | Haan et al. | Jul 1997 | A |
5695583 | van den Bergh et al. | Dec 1997 | A |
5729092 | Doiron et al. | Mar 1998 | A |
5730700 | Walther et al. | Mar 1998 | A |
5733277 | Pallarito | Mar 1998 | A |
5756145 | Darouiche | May 1998 | A |
5807390 | Fuller et al. | Sep 1998 | A |
5824005 | Motamedi et al. | Oct 1998 | A |
5854422 | McKeon et al. | Dec 1998 | A |
5876426 | Kume et al. | Mar 1999 | A |
5891082 | Leone et al. | Apr 1999 | A |
5891136 | McGee et al. | Apr 1999 | A |
5911720 | Bourne et al. | Jun 1999 | A |
5947958 | Woodard et al. | Sep 1999 | A |
5997571 | Farr et al. | Dec 1999 | A |
6013053 | Bower et al. | Jan 2000 | A |
6027524 | Petit | Feb 2000 | A |
6086558 | Bower et al. | Jul 2000 | A |
6096030 | Ortiz | Aug 2000 | A |
6146409 | Overholt | Nov 2000 | A |
6270492 | Sinofsky | Aug 2001 | B1 |
6391052 | Buirge et al. | May 2002 | B2 |
6398779 | Gu et al. | Jun 2002 | B1 |
6423055 | Farr et al. | Jul 2002 | B1 |
6471692 | Eckhouse | Oct 2002 | B1 |
6482197 | Finch et al. | Nov 2002 | B2 |
6500174 | Maguire | Dec 2002 | B1 |
6514245 | Williams | Feb 2003 | B1 |
6522806 | James, IV et al. | Feb 2003 | B1 |
6524274 | Rosenthal et al. | Feb 2003 | B1 |
6562029 | Maki et al. | May 2003 | B2 |
6572609 | Farr et al. | Jun 2003 | B1 |
6602246 | Joye | Aug 2003 | B1 |
6616653 | Beyar et al. | Sep 2003 | B2 |
6626900 | Sinofsky et al. | Sep 2003 | B1 |
6706004 | Tearney et al. | Mar 2004 | B2 |
6708056 | Duchon et al. | Mar 2004 | B2 |
6796972 | Sinofsky et al. | Sep 2004 | B1 |
6829411 | Easley | Dec 2004 | B2 |
6837885 | Koblish et al. | Jan 2005 | B2 |
6899706 | Siatkine | May 2005 | B2 |
6953457 | Farr et al. | Oct 2005 | B2 |
6986764 | Davenport et al. | Jan 2006 | B2 |
7112195 | Boll et al. | Sep 2006 | B2 |
7131963 | Hyde | Nov 2006 | B1 |
7135034 | Friedman et al. | Nov 2006 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7207984 | Farr et al. | Apr 2007 | B2 |
7261730 | Friedman et al. | Aug 2007 | B2 |
7357796 | Farr et al. | Apr 2008 | B2 |
7359601 | Loeb | Apr 2008 | B2 |
7449026 | Zalesky et al. | Nov 2008 | B2 |
7559925 | Goldfarb | Jul 2009 | B2 |
7905874 | Miller et al. | Mar 2011 | B2 |
8016748 | Mourlas | Sep 2011 | B2 |
8241273 | Whayne | Aug 2012 | B2 |
8876807 | Evans et al. | Nov 2014 | B2 |
8936592 | Beck et al. | Jan 2015 | B2 |
20020013601 | Nobles | Jan 2002 | A1 |
20020045894 | Joye | Apr 2002 | A1 |
20020161358 | Liu | Oct 2002 | A1 |
20020183731 | Holland | Dec 2002 | A1 |
20020193850 | Selman | Dec 2002 | A1 |
20030036752 | Joye | Feb 2003 | A1 |
20040002749 | Joye | Jan 2004 | A1 |
20040082859 | Schaer | Apr 2004 | A1 |
20040133254 | Sterzer et al. | Jul 2004 | A1 |
20050203496 | Ritchie | Sep 2005 | A1 |
20050255039 | Desai | Nov 2005 | A1 |
20070032783 | Abboud | Feb 2007 | A1 |
20070197896 | Moll | Aug 2007 | A1 |
20070282403 | Tearney | Dec 2007 | A1 |
20080039828 | Jimenez et al. | Feb 2008 | A1 |
20080281317 | Gobel | Nov 2008 | A1 |
20090138000 | Vancelette | May 2009 | A1 |
20100298757 | Frigstad | Nov 2010 | A1 |
20110301584 | Beck et al. | Dec 2011 | A1 |
20120157981 | Evans et al. | Jun 2012 | A1 |
Entry |
---|
Non-Final Office Action related to U.S. Appl. No. 13/330,038, dated Feb. 27, 2014. |
Final Office Action related to U.S. Appl. No. 13/152,825, dated May 28, 2014. |
Non-Final Office Action related to U.S. Appl. No. 13/330,038, dated Nov. 8, 2013. |
Non-Final Office Action related to U.S. Appl. No. 13/330,038, dated Aug. 12, 2013. |
Non-Final Office Action related to U.S. Appl. No. 13/152,825, dated May 8, 2013. |
U.S. Appl. No. 12/468,668, filed May 19, 2009. |
Pietrafitta, Joseph J., MD, “Laser Therapy of Cancer of the Gastrointestinal and Biliary Tracts”, Seminars in Surgical Oncology 5:17-29, 1989. |
Number | Date | Country | |
---|---|---|---|
20170007326 A1 | Jan 2017 | US |
Number | Date | Country | |
---|---|---|---|
61351127 | Jun 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14521831 | Oct 2014 | US |
Child | 15209120 | US | |
Parent | 13152825 | Jun 2011 | US |
Child | 14521831 | US |